New Paragraph
NEWS & EVENTS
ENDOSURE, Inc. appoints Ferdinand Medical as the exclusive Nordic distributor for non-invasive endometriosis test.
ENDOSURE, Inc. appoints LAWMED as UK distributors for their revolutionary test to diagnose endometriosis in 30 minutes
Game Changing New Test for Endometriosis, Poised to End the Misery of Women Worldwide -
View the Press Release
ENDOSURE, INC. INTRODUCES FIRST NON-INVASIVE, HIGHLY ACCURATE, 30-MINUTE DIAGNOSTIC TEST FOR ENDOMETRIOSIS AT AAGL - View the Press Release
About Us
EndoSure offers the only non-invasive, 30-minute test to support the diagnosis of endometriosis that not only fills the gap, but addresses the vacuum in this area of women’s health care.*
© July 2023 ENDOSURE, Inc. All rights reserved
1. Approximately 15-20 minutes of patient preparation time may be required prior to performing the test.
2. Mathias JR, Franklin R, Quast DC, Fraga N, Loftin CA, Yates L, Harrison V. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.
3. Noar M. AI-derived threshold score of intraabdominal myoelectrical activity predicts presence and stage of endometriosis with 100% accuracy. J Minim Invasive Gynecol. 2022 Nov;29(11):S4-S5.
4. Zondervan, K.T.; Becker, C.M.; Koga, K.; Missmer, S.A.; Taylor, R.N.; Viganò, P. Endometriosis. Nat. Rev. Dis. Primers. 2018:4-9.
DISCLAIMER: THE ENDOSURE TEST IS A CLINICAL DECISION SUPPORT TOOL INTENDED TO INFORM AND ENHANCE A HEALTHCARE PROVIDER'S DECISION-MAKING PROCESS, WHICH MUST BE INDIVIDUALIZED FOR EACH PATIENT'S CIRCUMSTANCES AND TAKE INTO ACCOUNT THE FULL SCOPE OF MEDICAL DATA AND INFORMATION AVAILABLE TO THE PROVIDER. THE ENDOSURE TEST IS NOT INTENDED TO SUBSTITUTE, REPLACE, OVERRULE, OR DIRECT A HEALTHCARE PROVIDER’S JUDGMENT.
* US CUSTOMERS: Endosure is currently available for research use only and not clinical use.